Evidence map›Paper›PMID 27670521›Full record

ArticleBMJ open2016

Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial.

Padraig Dixon, Sandra Hollinghurst, Roberta Ara, Louisa Edwards, Alexis Foster, Chris Salisbury

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
12.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Supporting the Quadruple Aim Using Simulation and Human Factors During COVID-19 Care.American journal of medical quality : the official journal of the American College of Medical Quality
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Padraig DixonCentre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Sandra HollinghurstCentre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0003-0782-3117
Roberta AraScHARR, The University of Sheffield, Sheffield, UK.
Louisa EdwardsCentre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Alexis FosterScHARR, The University of Sheffield, Sheffield, UK.
Chris SalisburyCentre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0002-4378-3960
University of Bristol · GBUniversity of Sheffield · GB

Funding

Department of Health RP-PG-0108-10011
6 · The paper itself

Abstract

objectivesTo investigate the long-term cost-effectiveness (measured as the ratio of incremental NHS cost to incremental quality-adjusted life years) of a telehealth intervention for patients with raised cardiovascular disease (CVD) risk.

designA cohort simulation model developed as part of the economic evaluation conducted alongside the Healthlines randomised controlled trial.

settingPatients recruited through primary care, and intervention delivered via telehealth service.

participantsParticipants with a 10-year CVD risk ≥20%, as measured by the QRISK2 algorithm, and with at least 1 modifiable risk factor, individually randomised from 42 general practices in England.

interventionA telehealth service delivered over a 12-month period. The intervention involved a series of responsive, theory-led encounters between patients and trained health information advisors who provided access to information resources and supported medication adherence and coordination of care. PRIMARY AND SECONDARY OUTCOME MEASURES: Cost-effectiveness measured by net monetary benefit over the simulated lifetime of trial participants from a UK National Health Service perspective.

resultsThe probability that the intervention was cost-effective depended on the duration of the effect of the intervention. The intervention was cost-effective with high probability if effects persisted over the lifetime of intervention recipients. The probability of cost-effectiveness was lower for shorter durations of effect.

conclusionsThe intervention was likely to be cost-effective under a lifetime perspective. TRIAL REGISTRATION NUMBER: ISRCTN27508731; Results.

Indexed as

AnginaHEALTH ECONOMICSSTROKE MEDICINE

Identifiers

PMID27670521
PMCPMC5051382
OpenAlexW2525382191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.